Common Contracts

2 similar Investor's Rights Agreement contracts by Aptose Biosciences Inc., Hanmi Pharmaceutical Co., Ltd.

SECOND AMENDED AND RESTATED INVESTOR’S RIGHTS AGREEMENT
Investor's Rights Agreement • March 24th, 2025 • Aptose Biosciences Inc. • Biological products, (no disgnostic substances) • New York

This SECOND AMENDED AND RESTATED INVESTOR’S RIGHTS AGREEMENT (this “Agreement”), is made as of March 18, 2025, by and between Aptose Biosciences Inc., a Canadian corporation (the “Company”), and Hanmi Pharmaceutical Co., Ltd., a corporation incorporated under the laws of the Republic of Korea (the “Investor”).

SECOND AMENDED AND RESTATED INVESTOR’S RIGHTS AGREEMENT
Investor’s Rights Agreement • March 20th, 2025 • Hanmi Pharmaceutical Co., Ltd. • Biological products, (no disgnostic substances) • New York

This SECOND AMENDED AND RESTATED INVESTOR’S RIGHTS AGREEMENT (this “Agreement”), is made as of March 18, 2025, by and between Aptose Biosciences Inc., a Canadian corporation (the “Company”), and Hanmi Pharmaceutical Co., Ltd., a corporation incorporated under the laws of the Republic of Korea (the “Investor”).